News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Lenovo delivers strongest quarter in Group history: Hybrid AI strategy powers growth momentum HONG KONG, August 13, 2026--(BUSINESS WIRE)--Lenovo GroupLimited (HKSE: 992) (ADR: LNVGY), together with its subsidiaries ('the Group'), today reported first quarter results for fiscal year 2026/27, marking the highest quarterly revenue …
Sharemaestro market context Trend signal active 52 weeks +215.9%Earnings Call Insights: Enovix Corporation (ENVX) Q2 2026 MANAGEMENT VIEW * “The second quarter showed momentum across all 3 of our primary target markets,” and in smartphones “our lead customer confirmed that our cells passed more than 1,000 cycles on the 0.2C discharge cycle …
Tenon Medical Inc (TNON) is scheduled to release its Q2 2026 earnings on August 13, 2026, with anticipated revenues of $1.54 million and earnings of -0.24 per share. Analyst estimates for both revenue and earnings for 2026 and 2027 have seen slight increases over …
Argus has raised its target price for Cenovus Energy Inc (CVE) to $33.00, citing the company's focus on creating value through its oil sands assets. Cenovus Energy Inc is described as an integrated oil company. The current price for CVE is $29.89.
Enovix Corporation (ENVX) stock closed at $4.73, retreating from an intraday high, with its daily chart remaining in a downtrend despite some short-term bounce signals. While daily momentum indicators suggest a pause, not a reversal, hourly charts indicate that the bounce is losing conviction …
Kenon Holdings Ltd (KEN) shares surged 6.2% to $68.07, but GuruFocus indicates the stock is significantly overvalued by 50% compared to its estimated fair value of $45.39, despite having a GF Score of 70/100 driven by strong momentum. The company is unprofitable and cash-flow …
RenovoRx, Inc. (RNXT) reported a Q2 loss of $0.05 per share, surpassing the Zacks Consensus Estimate of a $0.08 loss and an improvement from last year's $0.08 loss. The company also exceeded revenue estimates, posting $0.91 million against an expected $0.73 million. Despite outperforming …
Enovix (ENVX) reported a smaller-than-expected Q2 2026 loss and higher revenue, yet its shares declined after hours due to investor concerns over near-term margin pressure. The company highlighted progress in smartphone qualification, smart eyewear production, and a growing defense pipeline. Despite beating estimates, the …
RenovoRx announced record financial results for the second quarter of 2026, with revenue reaching $909,000, marking a 61% sequential quarterly increase and a 115% year-over-year increase. The company raised its 2026 annual revenue guidance to a range of $3.75 million to $4.25 million, driven …
RenovoRx (NASDAQ:RNXT) reported a narrower-than-expected quarterly loss of $0.05 per share, surpassing consensus estimates by $0.02. The company also saw significant revenue growth, climbing 61% sequentially and 115% year-over-year to $909,000, leading management to raise its 2026 revenue guidance. Despite this progress, RenovoRx remains …
RenovoRx announced a strong Q2 2026 performance, exceeding Wall Street expectations with higher-than-forecasted revenue of $909,000 and a smaller loss of 6 cents per share. The medical device company raised its full-year 2026 revenue guidance to $3.75 million to $4.25 million, citing record quarterly …
Enovix Corporation (ENVX) reported a Q2 loss of $0.13 per share, exceeding the Zacks Consensus Estimate of a $0.14 loss, and surpassed revenue estimates with $9.02 million. Despite consistently beating EPS estimates over the last four quarters, the company's shares have declined 33.9% year-to-date. …
Enovix Corporation reported Q2 revenue of $9 million, surpassing FactSet's estimate of $8.4 million. The company also released its Q3 outlook, expecting a non-GAAP net loss per share between $0.17 and $0.13 and revenue ranging from $9 million to $10 million. Enovix specializes in …
ServiceNow partner Brightfin, in collaboration with Knox Systems, has achieved FedRAMP Moderate Authorization for its IT Financial Management and Technology Expense Management solution built on ServiceNow. This authorization allows U.S. federal agencies to use Brightfin's AI-powered expense management, meeting strict security and compliance standards. …
Enovix Corporation reported increased revenue for both the fiscal quarter and year-to-date periods ending July 5, 2026, primarily driven by sales to defense and industrial customers. Despite revenue growth, the company experienced wider net losses for the year-to-date, reaching $81.3 million, largely due to …
Enovix Corp (ENVX) reported its second-quarter 2026 results, showing a revenue increase to $9.02M, up 20.8% year-over-year. Despite the revenue growth, the company posted a net loss of ($43.06M) and a diluted loss per share of ($0.2). Business highlights include the launch of the …
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. ServiceNow (NOW) is back in focus after a beat and raise second quarter, where revenue and profitability came in ahead of company guidance and annual …
Sharemaestro market context Price above Trend Line 52 weeks -35.7%Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The consensus analyst price target fair value for Amphenol has shifted from US$189.39 to …
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup negative 33.8%NeoGenomics' Senior VP & Chief Accounting Officer, Gregory Aunan, recently sold US$321k worth of shares, representing an 80% reduction in his holdings at an average price of US$16.07. This significant insider selling event, occurring slightly below the current share price of US$16.53, raises caution …
This page provides a comprehensive list of Kenon Holdings Ltd.'s SEC filings and other financial documents, including quarterly and annual earnings releases from 2023 to 2026. Each entry briefly highlights key financial and operational achievements or challenges for the respective period. This resource is …
Maxim Group has reiterated its Buy rating for Bionano Genomics (BNGO.US), along with a maintained target price of $4. This indicates a continued positive outlook from the firm regarding the company's stock performance and valuation.
Amphenol APH shares closed at $167.23 on Aug. 11, very close to the 52-week high of $178.52 hit on June 30. APH's shares have risen 23.8% year to date (YTD), outperforming the Zacks Computer and Technology sector's appreciation of 16.9%. The outperformance can be …
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup negative 33.8%Cenovus Energy Inc. (CVE) shares rose 1.32% to C$42.11 on Wednesday, outperforming the S&P/TSX Composite Index, which increased by 0.51%. The stock closed 4.6% below its 52-week high of C$44.13. This performance occurred during a generally favorable trading session for the Canadian market.
Scotiabank has increased its price target for Terreno Realty (NYSE:TRNO) to $72.00 from $68.00, maintaining a "sector outperform" rating and suggesting a 5.33% upside. Other analysts have also adjusted their price targets, contributing to a consensus "Moderate Buy" rating and an average target of …
ServiceNow (NOW) shares dropped 3.6% as investors engaged in profit-taking and considered valuation concerns following a recent post-earnings rally. Despite a solid Q2 update on July 22, which showed strong subscription revenue growth and an increased full-year outlook, the stock's volatility in 2026 indicates …
ServiceNow (NOW) is experiencing renewed institutional confidence following a Wells Fargo upgrade and the launch of new AI-native security tools, contributing to a billion-dollar annualized AI revenue run rate. Social media sentiment is cautiously optimistic, with traders monitoring technical resistance and support levels. Insider …
KeyBanc raised its price target for Terreno Realty Corp (NYSE:TRNO) to $75 from $72, maintaining an Overweight rating due to strong leasing momentum and active acquisitions. The firm noted incremental activity from defense, aerospace, and advanced manufacturing tenants, along with stronger-than-expected leasing spreads. Despite …
Freenome has received FDA Breakthrough Device Designation for its investigational SimpleScreen™ Lung test, a blood-based screening tool for lung cancer. The test is designed for high-risk adults aged 50-80 with a significant smoking history who are not currently undergoing recommended screening, aiming to address …
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Let's …
Sharemaestro market context Price above Trend Line 52 weeks -35.7%Analysts have significantly cut their revenue and increased their loss per share estimates for Metagenomi Therapeutics, Inc. (NASDAQ:MGX) for 2026. The new consensus predicts a substantial 43% decline in revenue and increased losses per share compared to previous forecasts. This revision suggests a more …
RenovoRx Inc (RNXT) reported record Q2 2026 revenue of $909,000, a 61% sequential and 115% year-over-year increase, driven by an expanded commercial presence in cancer centers. The company also announced full enrollment for its Phase 3 TIGERPAC trial, with top-line data expected in late …
GCM Grosvenor (GCMG) reported strong Q2 2026 results with fee-related earnings up 21% and AUM increasing by 13% year-on-year, but its stock performance only saw a modest 1% increase. Investors are weighing the company's durable fee power against the concentration risk associated with its …
Search by ticker symbol or company name and select a result to open its chart.